KR900702005A - 탄수화물과 탄수화물 유도체를 사용하는 비루스-숙주세포 상호작용의 변조방법 - Google Patents

탄수화물과 탄수화물 유도체를 사용하는 비루스-숙주세포 상호작용의 변조방법

Info

Publication number
KR900702005A
KR900702005A KR1019900700466A KR900700466A KR900702005A KR 900702005 A KR900702005 A KR 900702005A KR 1019900700466 A KR1019900700466 A KR 1019900700466A KR 900700466 A KR900700466 A KR 900700466A KR 900702005 A KR900702005 A KR 900702005A
Authority
KR
South Korea
Prior art keywords
virus
cells
cyclodextrins
chemically modified
inhibiting
Prior art date
Application number
KR1019900700466A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of KR900702005A publication Critical patent/KR900702005A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2006—IL-1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR1019900700466A 1988-07-07 1990-03-05 탄수화물과 탄수화물 유도체를 사용하는 비루스-숙주세포 상호작용의 변조방법 KR900702005A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21617688A 1988-07-07 1988-07-07
US37300589A 1989-06-28 1989-06-28
PCT/US1989/002944 WO1990000596A1 (en) 1988-07-07 1989-07-06 Method of modulating virus-host cell interactions using carbohydrates and carbohydrate derivatives

Publications (1)

Publication Number Publication Date
KR900702005A true KR900702005A (ko) 1990-12-05

Family

ID=26910735

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019900700466A KR900702005A (ko) 1988-07-07 1990-03-05 탄수화물과 탄수화물 유도체를 사용하는 비루스-숙주세포 상호작용의 변조방법

Country Status (10)

Country Link
EP (1) EP0423240B1 (ko)
JP (1) JPH04500456A (ko)
KR (1) KR900702005A (ko)
AT (1) ATE129897T1 (ko)
AU (1) AU636850B2 (ko)
DE (1) DE68924774T2 (ko)
IE (1) IE75688B1 (ko)
PT (1) PT91088B (ko)
WO (1) WO1990000596A1 (ko)
ZA (1) ZA895187B (ko)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69104877T2 (de) * 1990-03-15 1995-03-16 Tanabe Seiyaku Co Polysulfat eines Cyclodextrinderivates und Verfahren zu dessen Herstellung.
US5248675A (en) * 1990-03-15 1993-09-28 Tanabe Seiyaku Co., Ltd. Polysulfate of cyclodextrin derivative and process for preparing the same
GB9020872D0 (en) * 1990-09-25 1990-11-07 Ml Lab Plc Pharmaceutical compositions and use thereof
FR2669535A1 (fr) * 1990-11-26 1992-05-29 Medgenix Group Sa Utilisation a titre de medicament de macromolecules polysulfonees.
US5312837A (en) * 1991-01-29 1994-05-17 Genelabs Technologies, Inc. Method of treating viral infections with aryl macrocyclic compounds
JP2556236B2 (ja) * 1991-08-29 1996-11-20 田辺製薬株式会社 β−シクロデキストリン誘導体のポリ硫酸エステル及びその製法
WO1994003164A1 (en) * 1992-08-06 1994-02-17 Genelabs Technologies, Inc. Inhibition and treatment of infection by enveloped virus with calix(n) arene compounds
DE9316320U1 (de) * 1993-10-20 1994-01-20 Beni Med Natuerliche Heilmitte Kosmetische Zubereitung in Form von Lippenstiften mit antiviraler Wirkung
US5691316A (en) * 1994-06-01 1997-11-25 Hybridon, Inc. Cyclodextrin cellular delivery system for oligonucleotides
US6835717B2 (en) 2000-03-08 2004-12-28 The Johns Hopkins University School Of Medicine β-cyclodextrin compositions, and use to prevent transmission of sexually transmitted diseases
DE10203999A1 (de) * 2002-02-01 2003-08-14 Nutricia Nv Cycloglycane
BE1030002B1 (fr) 2021-12-29 2023-09-01 Aquilon Pharmaceuticals Compositions inhalables comprenant un complexe de hpbcd et de budesonide ou ciclesonide pour le traitement ou la prevention d'une maladie virale respiratoire
WO2023118014A1 (en) 2021-12-20 2023-06-29 Aquilon Pharmaceuticals Inhalable compositions comprising a complex of hpbcd and budesonide or ciclesonide for the treatment or prevention of a respiratory viral disease or lipopolysaccharide-induced inflammation, in particular lipopolysaccharide-induced inflammation associated with a respiratory viral disease

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4783446A (en) * 1985-11-22 1988-11-08 Neushul Mariculture Incorporated Method for the treatment of AIDS virus and other retroviruses

Also Published As

Publication number Publication date
ZA895187B (en) 1990-04-25
JPH04500456A (ja) 1992-01-30
EP0423240A1 (en) 1991-04-24
IE75688B1 (en) 1997-09-10
AU636850B2 (en) 1993-05-13
PT91088A (pt) 1990-02-08
DE68924774D1 (de) 1995-12-14
AU4044389A (en) 1990-02-05
EP0423240A4 (en) 1992-07-22
IE892183L (en) 1990-01-07
PT91088B (pt) 1995-01-31
EP0423240B1 (en) 1995-11-08
WO1990000596A1 (en) 1990-01-25
ATE129897T1 (de) 1995-11-15
DE68924774T2 (de) 1996-05-02

Similar Documents

Publication Publication Date Title
KR900702005A (ko) 탄수화물과 탄수화물 유도체를 사용하는 비루스-숙주세포 상호작용의 변조방법
DK0934310T3 (da) Thiosyreafledte, monocykliske forbindelser som antikoaguleringsmidler
BRPI9809791B8 (pt) compostos imuno efetores de fosfato de aminoalquil glucosamina e composições compreendendo os mesmos
ES2058725T3 (es) Aplicacion transdermica de 2-amino-6-n-propilamino-4,5,6,7-tetrahidrobenzotiazol.
BG46598A3 (en) Method for preparation of alpha- heterocyclic substituted tolunitriles
DK0658348T3 (da) Vandige opløsninger af inklusionskomplekser af benzothiophenforbindelser og cyclodextriner
DE69434497D1 (de) Verwendung von alpha-1,4-glukanlyase zur herstellung von 1,5 d-anhydrofruktose
TR25385A (tr) Nem ile sertlesen bir bilesenli polisilokzan bilesigi
DE68905117D1 (de) Verfahren zur stabilisierung von blutgewinnungsfaktoren.
ATE86504T1 (de) Verfahren und geraete zur desinfektion von materialien mit ueberhitztem dampf.
NO854734L (no) Fremgangsmaate for gjenvinning av opploeselige karbohydrater inneholdt i ved.
DK640587A (da) Cytostatisk virksomme anthracyclinderivater cytostatisk virksomme anthracyclinderivater
ES2017711B3 (es) Una composición lavavajillas enzimática.
DE68923636D1 (de) Halbleiter-Treiber zur Erzeugung von Schalt- und Offset-Signalen.
ECSP930949A (es) Derivados de 2- imidazolina -5- onas y 2- imidazolina- 5 tionas fungicidas
MX171222B (es) Composiciones no dulces con sabor apetitoso, usando un agente de voluminosiad de carbohidrato no dulce
NO873902D0 (no) Fremgangsmaate for aa forbedre overflaters evne til aa motstaa isdannelse eller aa fjerne allerede dannet is.
NO173110C (no) Fremgangsmaate for avsetning av flytepunkt-nedsettende middel i en oljeproduserende formasjon
AR009105A1 (es) Derivados de n-(benzotiazol-2-il) piperidina-1-etanamina, su preparacion y aplicacion en terapeutica
ES2174955T3 (es) Sulfatacion regioselectiva.
AR019701A1 (es) Compuestos derivados de alfa-d-xilosa, preparacion y su utilizacion en terapeutica
IT8921549A0 (it) Procedimento per la tintuta o la stampa di substrati cellulosici con coloranti allo zolfo.
TR199600117A2 (tr) Ikame edilen benzolsülfonilüre ve tiyoüre, bu maddelerin elde edilmesi ve eczanecilikle ilgili maddelerin bu bilesimler ve bu bilesimleri iceren iyilestirici maddelere dayanarak kullanilmasi ile ilgili usul.
ATE100462T1 (de) 19-fluor- oder cyano-21-hydroxy-progesteronderivate als 19-hydroxylase-inhibitoren.
DE69936405D1 (de) Verwendung einer Zusammensetzung um das Anhaften von Keimen auf der Haut zu verhindern

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application